Grindwell Norton Limited (NSE:GRINDWELL)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	162,542	186,702	210,268	207,589	199,230	105,450
Market Cap Growth	-36.75%	-11.21%	1.29%	4.20%	88.93%	107.31%
Enterprise Value	154,738	181,011	204,773	203,085	193,062	100,716
Last Close Price	1468.00	1679.99	1870.92	1837.11	1748.14	918.06
PE Ratio	43.93	50.64	54.81	57.36	67.39	44.09
PS Ratio	5.79	6.64	7.83	8.17	9.90	6.44
PB Ratio	7.16	8.23	10.17	11.43	12.61	7.66
P/TBV Ratio	7.52	8.64	10.72	12.13	12.79	7.78
P/FCF Ratio	-	51.23	107.52	292.22	326.66	37.27
P/OCF Ratio	-	40.72	57.15	52.88	106.78	31.83
EV/Sales Ratio	5.51	6.44	7.62	7.99	9.59	6.15
EV/EBITDA Ratio	30.52	36.64	40.61	40.66	49.31	32.01
EV/EBIT Ratio	37.32	42.94	45.64	45.12	55.58	37.34
EV/FCF Ratio	-	49.67	104.71	285.88	316.54	35.60
Debt / Equity Ratio	0.04	0.04	0.04	0.03	0.01	0.01
Debt / EBITDA Ratio	0.17	0.16	0.16	0.10	0.04	0.04
Debt / FCF Ratio	-	0.23	0.42	0.72	0.25	0.04
Asset Turnover	-	0.97	1.04	1.12	1.01	0.95
Inventory Turnover	-	2.64	2.57	2.58	2.34	2.32
Quick Ratio	-	1.98	1.80	1.72	1.75	1.98
Current Ratio	-	2.83	2.76	2.77	2.82	2.86
Return on Equity (ROE)	-	17.12%	19.77%	21.29%	19.96%	18.45%
Return on Assets (ROA)	-	9.04%	10.83%	12.42%	10.90%	9.75%
Return on Capital (ROIC)	11.49%	11.70%	13.96%	16.25%	14.55%	12.91%
Return on Capital Employed (ROCE)	-	17.40%	20.40%	23.50%	21.30%	18.90%
Earnings Yield	2.28%	1.98%	1.82%	1.74%	1.48%	2.27%
FCF Yield	-	1.95%	0.93%	0.34%	0.31%	2.68%
Dividend Yield	1.16%	1.01%	0.91%	0.79%	0.69%	1.03%
Payout Ratio	-	51.05%	41.85%	36.71%	35.58%	34.72%
Total Shareholder Return	1.13%	1.01%	0.91%	0.79%	0.69%	1.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.